Health Insurance Coverage Disruptions and Cancer Care and Outcomes: Systematic Review of Published Research

Lack of health insurance coverage is associated with poor access and receipt of cancer care and survival in the United States. Disruptions in coverage are common among low-income populations, but little is known about associations of disruptions with cancer care, including prevention, screening, and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JNCI : Journal of the National Cancer Institute Ročník 112; číslo 7; s. 671
Hlavní autoři: Yabroff, K Robin, Reeder-Hayes, Katherine, Zhao, Jingxuan, Halpern, Michael T, Lopez, Ana Maria, Bernal-Mizrachi, Leon, Collier, Anderson B, Neuner, Joan, Phillips, Jonathan, Blackstock, William, Patel, Manali
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.07.2020
Témata:
ISSN:1460-2105, 1460-2105
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Lack of health insurance coverage is associated with poor access and receipt of cancer care and survival in the United States. Disruptions in coverage are common among low-income populations, but little is known about associations of disruptions with cancer care, including prevention, screening, and treatment, as well as outcomes of stage at diagnosis and survival. We conducted a systematic review of studies of health insurance coverage disruptions and cancer care and outcomes published between 1980 and 2019. We used the PubMed, EMBASE, Scopus, and CINAHL databases and identified 29 observational studies. Study characteristics and key findings were abstracted and synthesized qualitatively. Studies evaluated associations between coverage disruptions and prevention or screening (31.0%), treatment (13.8%), end-of-life care (10.3%), stage at diagnosis (44.8%), and survival (20.7%). Coverage disruptions ranged from 4.3% to 32.8% of patients age-eligible for breast, cervical, or colorectal cancer screening. Between 22.1% and 59.5% of patients with Medicaid gained coverage only at or after cancer diagnosis. Coverage disruptions were consistently statistically significantly associated with lower receipt of prevention, screening, and treatment. Among patients with cancer, those with Medicaid disruptions were statistically significantly more likely to have advanced stage (odds ratios = 1.2-3.8) and worse survival (hazard ratios = 1.28-2.43) than patients without disruptions. Health insurance coverage disruptions are common and adversely associated with receipt of cancer care and survival. Improved data infrastructure and quasi-experimental study designs will be important for evaluating the associations of federal and state policies on coverage disruptions and care and outcomes.
AbstractList Lack of health insurance coverage is associated with poor access and receipt of cancer care and survival in the United States. Disruptions in coverage are common among low-income populations, but little is known about associations of disruptions with cancer care, including prevention, screening, and treatment, as well as outcomes of stage at diagnosis and survival.BACKGROUNDLack of health insurance coverage is associated with poor access and receipt of cancer care and survival in the United States. Disruptions in coverage are common among low-income populations, but little is known about associations of disruptions with cancer care, including prevention, screening, and treatment, as well as outcomes of stage at diagnosis and survival.We conducted a systematic review of studies of health insurance coverage disruptions and cancer care and outcomes published between 1980 and 2019. We used the PubMed, EMBASE, Scopus, and CINAHL databases and identified 29 observational studies. Study characteristics and key findings were abstracted and synthesized qualitatively.METHODSWe conducted a systematic review of studies of health insurance coverage disruptions and cancer care and outcomes published between 1980 and 2019. We used the PubMed, EMBASE, Scopus, and CINAHL databases and identified 29 observational studies. Study characteristics and key findings were abstracted and synthesized qualitatively.Studies evaluated associations between coverage disruptions and prevention or screening (31.0%), treatment (13.8%), end-of-life care (10.3%), stage at diagnosis (44.8%), and survival (20.7%). Coverage disruptions ranged from 4.3% to 32.8% of patients age-eligible for breast, cervical, or colorectal cancer screening. Between 22.1% and 59.5% of patients with Medicaid gained coverage only at or after cancer diagnosis. Coverage disruptions were consistently statistically significantly associated with lower receipt of prevention, screening, and treatment. Among patients with cancer, those with Medicaid disruptions were statistically significantly more likely to have advanced stage (odds ratios = 1.2-3.8) and worse survival (hazard ratios = 1.28-2.43) than patients without disruptions.RESULTSStudies evaluated associations between coverage disruptions and prevention or screening (31.0%), treatment (13.8%), end-of-life care (10.3%), stage at diagnosis (44.8%), and survival (20.7%). Coverage disruptions ranged from 4.3% to 32.8% of patients age-eligible for breast, cervical, or colorectal cancer screening. Between 22.1% and 59.5% of patients with Medicaid gained coverage only at or after cancer diagnosis. Coverage disruptions were consistently statistically significantly associated with lower receipt of prevention, screening, and treatment. Among patients with cancer, those with Medicaid disruptions were statistically significantly more likely to have advanced stage (odds ratios = 1.2-3.8) and worse survival (hazard ratios = 1.28-2.43) than patients without disruptions.Health insurance coverage disruptions are common and adversely associated with receipt of cancer care and survival. Improved data infrastructure and quasi-experimental study designs will be important for evaluating the associations of federal and state policies on coverage disruptions and care and outcomes.CONCLUSIONSHealth insurance coverage disruptions are common and adversely associated with receipt of cancer care and survival. Improved data infrastructure and quasi-experimental study designs will be important for evaluating the associations of federal and state policies on coverage disruptions and care and outcomes.
Lack of health insurance coverage is associated with poor access and receipt of cancer care and survival in the United States. Disruptions in coverage are common among low-income populations, but little is known about associations of disruptions with cancer care, including prevention, screening, and treatment, as well as outcomes of stage at diagnosis and survival. We conducted a systematic review of studies of health insurance coverage disruptions and cancer care and outcomes published between 1980 and 2019. We used the PubMed, EMBASE, Scopus, and CINAHL databases and identified 29 observational studies. Study characteristics and key findings were abstracted and synthesized qualitatively. Studies evaluated associations between coverage disruptions and prevention or screening (31.0%), treatment (13.8%), end-of-life care (10.3%), stage at diagnosis (44.8%), and survival (20.7%). Coverage disruptions ranged from 4.3% to 32.8% of patients age-eligible for breast, cervical, or colorectal cancer screening. Between 22.1% and 59.5% of patients with Medicaid gained coverage only at or after cancer diagnosis. Coverage disruptions were consistently statistically significantly associated with lower receipt of prevention, screening, and treatment. Among patients with cancer, those with Medicaid disruptions were statistically significantly more likely to have advanced stage (odds ratios = 1.2-3.8) and worse survival (hazard ratios = 1.28-2.43) than patients without disruptions. Health insurance coverage disruptions are common and adversely associated with receipt of cancer care and survival. Improved data infrastructure and quasi-experimental study designs will be important for evaluating the associations of federal and state policies on coverage disruptions and care and outcomes.
Author Lopez, Ana Maria
Collier, Anderson B
Halpern, Michael T
Phillips, Jonathan
Bernal-Mizrachi, Leon
Patel, Manali
Neuner, Joan
Zhao, Jingxuan
Yabroff, K Robin
Reeder-Hayes, Katherine
Blackstock, William
Author_xml – sequence: 1
  givenname: K Robin
  surname: Yabroff
  fullname: Yabroff, K Robin
  organization: Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, USA
– sequence: 2
  givenname: Katherine
  surname: Reeder-Hayes
  fullname: Reeder-Hayes, Katherine
  organization: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA
– sequence: 3
  givenname: Jingxuan
  surname: Zhao
  fullname: Zhao, Jingxuan
  organization: Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, USA
– sequence: 4
  givenname: Michael T
  surname: Halpern
  fullname: Halpern, Michael T
  organization: Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA
– sequence: 5
  givenname: Ana Maria
  surname: Lopez
  fullname: Lopez, Ana Maria
  organization: Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA
– sequence: 6
  givenname: Leon
  surname: Bernal-Mizrachi
  fullname: Bernal-Mizrachi, Leon
  organization: Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
– sequence: 7
  givenname: Anderson B
  surname: Collier
  fullname: Collier, Anderson B
  organization: Children's Cancer Center, The University of Mississippi Medical Center, Jackson, MS, USA
– sequence: 8
  givenname: Joan
  surname: Neuner
  fullname: Neuner, Joan
  organization: Medical College of Wisconsin, Milwaukee, WI, USA
– sequence: 9
  givenname: Jonathan
  surname: Phillips
  fullname: Phillips, Jonathan
  organization: American Society of Clinical Oncology, Alexandria, VA, USA
– sequence: 10
  givenname: William
  surname: Blackstock
  fullname: Blackstock, William
  organization: Wake Forest School of Medicine, Winston-Salem, NC, USA
– sequence: 11
  givenname: Manali
  surname: Patel
  fullname: Patel, Manali
  organization: Stanford University School of Medicine, Stanford, CA, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32337585$$D View this record in MEDLINE/PubMed
BookMark eNpNkElPwzAQhS1URBe4cUY-cgl1vKQJNxSWIlUqYjlHE3tCUxKn2ElR_z2hFIm5vHnfPM3hjcnANhYJOQ_ZVcgSMV1bXU7NGoDJ-IiMQhmxgIdMDf7tQzL2fs36Sbg8IUPBhZipWI3Ixxyhalf00frOgdVI02aLDt6R3pbedZu2bKynYA1Nf86uF4d7v-xa3dTor-nLzrdYQ1tq-ozbEr9oU9CnLq9Kv0LTM4_g9OqUHBdQeTw76IS83d-9pvNgsXx4TG8WgZZStkEsJDLDBWAi8pwprk2OPVJFooWBcKZZlIQm4qDiIkYtQUUQFSbSRSJ1JPiEXP7-3bjms0PfZnXpNVYVWGw6n3GRKK5mfB-9OES7vEaTbVxZg9tlfwXxbyaEazs
CitedBy_id crossref_primary_10_1093_jnci_djaa049
crossref_primary_10_1186_s12992_023_00983_0
crossref_primary_10_1371_journal_pone_0292167
crossref_primary_10_1200_EDBK_389516
crossref_primary_10_1097_CMR_0000000000001059
crossref_primary_10_1097_SLA_0000000000006282
crossref_primary_10_1097_NCC_0000000000001539
crossref_primary_10_1016_j_jacr_2024_04_028
crossref_primary_10_1097_MLR_0000000000001675
crossref_primary_10_1177_10732748231218088
crossref_primary_10_3390_cancers17121898
crossref_primary_10_1007_s10552_021_01414_4
crossref_primary_10_1016_j_ejso_2022_12_001
crossref_primary_10_1007_s11764_024_01710_3
crossref_primary_10_1002_ijc_33880
crossref_primary_10_1016_j_sapharm_2023_02_005
crossref_primary_10_1016_j_clml_2024_07_017
crossref_primary_10_1097_MLR_0000000000001904
crossref_primary_10_1016_j_amepre_2022_09_023
crossref_primary_10_3322_caac_21812
crossref_primary_10_3322_caac_21732
crossref_primary_10_1002_cncr_35721
crossref_primary_10_1002_cam4_71105
crossref_primary_10_1002_cncr_33264
crossref_primary_10_1182_bloodadvances_2023010690
crossref_primary_10_1093_jnci_djae119
crossref_primary_10_1111_jdv_18458
crossref_primary_10_1245_s10434_024_15074_6
crossref_primary_10_1089_heq_2021_0115
crossref_primary_10_1093_jnci_djae111
crossref_primary_10_1001_jamanetworkopen_2025_18887
crossref_primary_10_1073_pnas_2426153122
crossref_primary_10_1200_OP_24_01075
crossref_primary_10_1093_jncics_pkac031
crossref_primary_10_3389_fpubh_2025_1591074
crossref_primary_10_3390_cancers15051392
crossref_primary_10_1080_14622416_2025_2490461
crossref_primary_10_1089_pop_2021_0211
crossref_primary_10_1002_cam4_70483
crossref_primary_10_30683_1929_2279_2025_14_09
crossref_primary_10_1007_s11764_021_01117_4
crossref_primary_10_1097_PPO_0000000000000580
crossref_primary_10_1177_10732748251347731
crossref_primary_10_4103_jehp_jehp_34_24
crossref_primary_10_1016_S1470_2045_25_00207_4
crossref_primary_10_1007_s00432_023_05088_0
crossref_primary_10_14423_SMJ_0000000000001549
crossref_primary_10_1093_jnci_djaf036
crossref_primary_10_1200_EDBK_320499
crossref_primary_10_1093_jnci_djac044
crossref_primary_10_1097_MLR_0000000000001779
crossref_primary_10_3390_cancers17030547
crossref_primary_10_1093_jnci_djae226
crossref_primary_10_3390_cancers16061117
crossref_primary_10_1093_carcin_bgaa121
crossref_primary_10_1007_s12029_025_01217_9
crossref_primary_10_1016_j_jtct_2021_01_022
crossref_primary_10_1186_s12905_023_02504_y
crossref_primary_10_1016_j_wneu_2024_09_064
crossref_primary_10_1007_s11764_024_01562_x
crossref_primary_10_1016_j_jss_2024_11_044
crossref_primary_10_1002_cncr_35342
crossref_primary_10_1002_cncr_35584
crossref_primary_10_1093_jnci_djab105
crossref_primary_10_1002_pros_24434
crossref_primary_10_1158_1940_6207_CAPR_24_0178
crossref_primary_10_1245_s10434_022_11755_2
crossref_primary_10_1016_j_amepre_2021_02_014
crossref_primary_10_1093_jncimonographs_lgad017
crossref_primary_10_1186_s12905_023_02264_9
crossref_primary_10_1182_bloodadvances_2024013532
crossref_primary_10_1001_jamanetworkopen_2025_1061
crossref_primary_10_1001_jama_2021_24294
crossref_primary_10_1002_jso_28011
crossref_primary_10_1093_jnci_djaa212
crossref_primary_10_1111_1475_6773_13901
crossref_primary_10_1002_pon_5815
crossref_primary_10_1148_rg_230008
crossref_primary_10_1093_jncics_pkac006
crossref_primary_10_1016_j_clbc_2023_11_006
ContentType Journal Article
Copyright Published by Oxford University Press 2020. This work is written by US Government employees and is in the public domain in the US.
Copyright_xml – notice: Published by Oxford University Press 2020. This work is written by US Government employees and is in the public domain in the US.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/jnci/djaa048
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1460-2105
ExternalDocumentID 32337585
Genre Systematic Review
Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NIMHD NIH HHS
  grantid: K23 MD013474
GroupedDBID ---
-E4
-~X
.2P
.I3
.XZ
.ZR
08P
0R~
1TH
29L
2WC
354
4.4
482
48X
5GY
5RE
5VS
5WD
70D
96U
AABZA
AACZT
AAHTB
AAJKP
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
ABCQX
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPPZ
ABPTD
ABQLI
ABQNK
ABVGC
ABXVV
ABZBJ
ACBMB
ACGFO
ACGFS
ACGOD
ACKOT
ACNCT
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
AEGPL
AEJOX
AEKSI
AEMDU
AEMQT
AENZO
AEPUE
AETBJ
AEWNT
AFAZI
AFFNX
AFFZL
AFIYH
AFOFC
AFRAH
AFXAL
AFYAG
AGINJ
AGKEF
AGORE
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
ATGXG
BAWUL
BAYMD
BCRHZ
BEYMZ
BTRTY
BVRKM
C45
CDBKE
CGR
CS3
CUY
CVF
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBS
ECM
EE~
EIF
EMOBN
ENERS
F5P
F8P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IH2
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
MHKGH
ML0
N9A
NGC
NOMLY
NOYVH
NPM
NU-
OAUYM
OAWHX
OBH
OCB
OCZFY
ODMLO
ODZKP
OGEVE
OHH
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q.-
Q1.
Q5Y
R44
RD5
RNS
ROL
ROX
ROZ
RUSNO
RW1
RXO
TCURE
TEORI
TJX
TMA
TR2
TWZ
UDS
UPT
VVN
W8F
WH7
WOQ
X7H
YAYTL
YKOAZ
YQT
YXANX
ZKX
ZRR
ZY1
~91
~H1
7X8
ID FETCH-LOGICAL-c444t-834e0d23ae93bb052cdbe4e05f9c3da17c0691d62a58f8ec4a56a6fd6cf94c632
IEDL.DBID 7X8
ISICitedReferencesCount 97
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000607821400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1460-2105
IngestDate Sun Sep 28 06:16:49 EDT 2025
Mon Jul 21 06:02:15 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License Published by Oxford University Press 2020. This work is written by US Government employees and is in the public domain in the US.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c444t-834e0d23ae93bb052cdbe4e05f9c3da17c0691d62a58f8ec4a56a6fd6cf94c632
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://academic.oup.com/jnci/article-pdf/112/7/671/33490524/djaa048.pdf
PMID 32337585
PQID 2395257263
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2395257263
pubmed_primary_32337585
PublicationCentury 2000
PublicationDate 2020-07-01
PublicationDateYYYYMMDD 2020-07-01
PublicationDate_xml – month: 07
  year: 2020
  text: 2020-07-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JNCI : Journal of the National Cancer Institute
PublicationTitleAlternate J Natl Cancer Inst
PublicationYear 2020
References 32337553 - J Natl Cancer Inst. 2020 Jul 1;112(7):657-658
References_xml – reference: 32337553 - J Natl Cancer Inst. 2020 Jul 1;112(7):657-658
SSID ssj0000924
Score 2.609477
SecondaryResourceType review_article
Snippet Lack of health insurance coverage is associated with poor access and receipt of cancer care and survival in the United States. Disruptions in coverage are...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 671
SubjectTerms Early Detection of Cancer - statistics & numerical data
Health Services Accessibility - statistics & numerical data
Humans
Insurance Coverage - statistics & numerical data
Insurance, Health - statistics & numerical data
Medicaid - statistics & numerical data
Medically Uninsured - statistics & numerical data
Neoplasms - diagnosis
Neoplasms - economics
Neoplasms - therapy
Observational Studies as Topic
Patient Protection and Affordable Care Act - statistics & numerical data
Poverty - statistics & numerical data
Publications - statistics & numerical data
United States
Title Health Insurance Coverage Disruptions and Cancer Care and Outcomes: Systematic Review of Published Research
URI https://www.ncbi.nlm.nih.gov/pubmed/32337585
https://www.proquest.com/docview/2395257263
Volume 112
WOSCitedRecordID wos000607821400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7eEF-8X-aNCL6Gtbkt8UVkOhR0Drywt5GeJLAJndrN32_Sdu5JEHwptCUQTk9Oz5fz5XwInSubeZpmlmjvBeGgU6IzTkkmFASXAmFLMubrfavbVf2-7tUbbkVNq5zFxDJQ2zHEPfImZTo27qSSXb5_kKgaFaurtYTGIlpmIZWJXt3qz7uFJ7oSteUyIQHaiJr4HkB8c5TDsGlHxiRc_Z5clj-ZzsZ_p7eJ1uv0El9V_rCFFly-jVYf6gL6Dnqrjh3hu7yYRkkNh9uRwxmCCr4eFp_TiuKCTW5xO77-xPGAUnn_OJ2EqbjiAj_9dH_GVWkBjz2e8estnpH5dtFL5-a5fUtqvQUCnPMJUYy7xFJmnGZZlggKNnPhkfAamDVpCxKpUyupEcorB9wIaaS3ErzmIBndQ0v5OHcHCIMP0SJAJR4SGq5TyAJMVWCkEQCJN6qBzmZmHAR_jkUKk7vxtBjMDdlA-9W3GLxXjTcGjDIW8c3hH0YfoTUaoXHJrD1Gyz6sZneCVuBrEsx5WjpKuHZ7D9-nDspZ
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Health+Insurance+Coverage+Disruptions+and+Cancer+Care+and+Outcomes%3A+Systematic+Review+of+Published+Research&rft.jtitle=JNCI+%3A+Journal+of+the+National+Cancer+Institute&rft.au=Yabroff%2C+K+Robin&rft.au=Reeder-Hayes%2C+Katherine&rft.au=Zhao%2C+Jingxuan&rft.au=Halpern%2C+Michael+T&rft.date=2020-07-01&rft.issn=1460-2105&rft.eissn=1460-2105&rft.volume=112&rft.issue=7&rft.spage=671&rft_id=info:doi/10.1093%2Fjnci%2Fdjaa048&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2105&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2105&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2105&client=summon